• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Diabetic Retinopathy  • Alert me on articles by topic  Social Bookmarking   What's this?

M. Cristina Leske, MD, MPH; Suh-Yuh Wu, MA; Anselm Hennis, MRCP(UK), PhD; Barbara Nemesure, PhD; Andrew P. Schachat, MD; Leslie Hyman, PhD; Ling Yang, MS; for the Barbados Eye Study Group

Arch Ophthalmol. 2006;124:250-255.

Objective  To estimate the 9-year incidence of diabetic retinopathy (DR) in a population with the same ancestry as African Americans.

Methods  Participants with diabetes mellitus and gradable photographs at the 9-year examination were evaluated (n = 436). The incidences of minimum/moderate/severe DR, clinically significant macular edema (CSME), and sight-threatening DR (severe DR plus CSME) were defined by the development of specific diabetic changes in persons without those conditions at baseline. Progression was defined as the development of severe/proliferative DR in persons with minimum/moderate DR at baseline.

Results  The 9-year DR incidence was 39.6% (38.0% for minimum, 9.0% for moderate, and 2.6% for severe/proliferative DR). Incidence tended to increase with diabetes duration and treatment. Of persons with preexisting DR at baseline, 8.2% progressed to proliferative DR. The CSME incidence was 8.7%, and it increased with diabetes duration, accounting for most of the overall incidence of sight-threatening DR.

Conclusions  The study provides new data on long-term incidence among persons of African origin. Results suggest a possible lower risk of severe/proliferative DR than in whites, while CSME incidence seems comparable or higher. The main component of sight-threatening DR was CSME, highlighting the importance of DR as a cause of vision loss in this population.

Author Affiliations: Department of Preventive Medicine, Stony Brook University, Stony Brook, NY (Drs Leske, Nemesure, and Hyman and Mss Wu and Yang); Ministry of Health, Bridgetown, and Chronic Disease Research Centre, School of Clinical Medicine and Research, University of the West Indies, Bridgetown, Barbados (Dr Hennis); and Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Md (Dr Schachat).

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease
Porepa et al.
CMAJ 2010;182:E526-E531.
ABSTRACT | FULL TEXT